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Background: The link between emotional stress and smoking has previously been investigated and results
have suggested that smoking is used as a way of dealing with stress. There are many studies indicating
the relationship between smoking and psoriasis or emotional stress and psoriasis. However, to our
knowledge, the link between smoking associated with emotional stress and psoriasis has not been
shown before. Our aim was to investigate psoriatic patients’ abilities to cope with stress, the relationship
between coping strategies and smoking habit.
Methods: Ninety-nine individuals with psoriasis (57 females, and 42 males, mean age: 37.4 years) were
included in this study. Sociodemographic information including age, sex, smoking habit, etc., was ob-
tained; Psoriasis Area Severity Index (PASI) scores were recorded. The Fagerstrom Test for Nicotine
Dependence was used on smoking patients to evaluate smoking habit or the degree of nicotine
dependence. The Ways of Coping Questionnaire and Dermatology Life Quality Index were ﬁlled out by all
patients. Data were assessed by comparing psoriatic smokers with nonsmokers and statistically analysis
was carried out with the SPSS 11.5 program.
Results: Forty patients (40.4%) were smokers. When comparing the two groups’ mechanisms of coping
with stress, smokers and nonsmokers coped with stress in similar ways. The seeking social support
scores from the Ways of Coping Questionnaire were signiﬁcantly lower in smokers than nonsmokers
(p< 0.05), while the Fagerstrom Test for Nicotine Dependence scores were correlated with distrustful
approach sub-scores, and PASI only correlated with smokers. The Dermatology Life Quality Index scores
were correlated with the PASI and distrustful approach scores in all patients.
Conclusion: Smoking and nonsmoking psoriatic patients had similar stress coping strategies, except the
subgroup seeking social support, and usually used positive ways of coping with stress. Psoriatic patients
who smoke might employ smoking to avoid stressful situations. They would beneﬁt from education on
adopting healthy stress management and, in turn, developing mature stress coping mechanisms. Future
prospective studies are required to address the exact causal link between smoking, psoriasis and psy-
chiatric comorbidity, including stress coping mechanisms.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Psoriasis is a chronic, inﬂammatory multisystem disease. It is
considered an immune-mediated disorder inﬂuenced by many
variables, such as genetic, environmental and psychosocial fac-
tors.1e3 The effects of all these factors on the development and
course of the disease have been demonstrated in numerous
studies so far. Stressful life events and smoking in response to
environmental/psychosocial trigger factors have been reported totırma Hastanesi, Dermatoloji
rkey. Tel.: þ90 212 3735000;
. Demirci).
iwanese Dermatological Associationegatively affect the onset and course of the disease, and are also
regarded as preventable causes of morbidity.1e4 Additionally,
smoking is an important contributing factor to cardiovascular co-
morbidity in psoriasis.5
Physical discomfort, psychological and social difﬁculties relating
to psoriasis may lead to psychiatric comorbidities and substance
abuse, such as smoking and alcohol abuse. While the prevalence of
smoking has been found to be signiﬁcantly higher among psoriasis
patients when compared to healthy controls, patients with high
stress levels report an increased frequency of psoriasis when
compared to people with low stress levels.6e8 These two factors,
emotional stress and smoking, also have a relationship with each
other. Based on these data, it may be considered that patients with
psoriasis may be smoking more due to emotional stress. Generallyn. Published by Elsevier Taiwan LLC. All rights reserved.
Table 2 Sociodemographic characteristics of the study group.
Sociodemographic characteristics Smokers (n) Nonsmokers (n) p
Sex
Male 20 22 0.147
Female 20 37
Age (years)a 36.73  11.02 37.86  14.11 0.541
Marital status
Married 11 13 0.449
Single 24 42
Divorced 5 4
Education (years)
8 34 33 0.118
9e12 5 17
>12 1 3
Chi-squared test was used for analysis.
a Independent group t-test was used for analysis.
Table 3 Disease-related characteristics of the patients.
Characteristics of psoriasis Smokers mean Nonsmokers mean p
Type of diseasea
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response to emotional stress, reducing anxiety.9,10 There are some
investigations that have assessed the link between smoking and
psoriasis or smoking and emotional stress separately.1e3,9e17
A few studies evaluating the relationship between cigarette
smoking, stressful life events and psoriasis have focused on the risk
factors and suggested that both smoking and stress may play an
important role in the onset or exacerbation of the disease.1,4,13,14,18
However, the relationship between emotional stress, smoking habit
and psoriasis seems to have been ignored from the psychological
viewpoint. The purpose of this study was to investigate the stress
coping mechanisms of psoriatic patients in the psychological
domain and to assess the difference between those who smoke and
those who do not smoke as a way of coping with stress, if any, and
to evaluate the relationship between nicotine dependence and
stress coping mechanisms. Hence, it may be considered that if
patients have maladaptive coping mechanisms and smokemore for
this reason, we can help them to develop more healthy coping
strategies and provide smoking cessation advice that may yield
substantial positive effects in preventing and managing smoking
related comorbidities and lead to a better overall clinical
outcome.13,17,19
Methods
A total of 99 psoriatic patients (57 females, and 42 males) over the
age of 15 years (mean age: 37.412.9 years) were included in the
study. Sociodemographic information (including age, sex, educa-
tion, marital status, smoking habits, systemic drug use, duration of
illness, etc) was obtained. Clinical severity was assessed with
Psoriasis Area and Severity Index (PASI) scores after examination;
additionally, the Dermatology Life Quality Index (DLQI) test
(Turkish version)20 was given to all patients to assess the impact of
the disease.
The patients were deﬁned as smokers and nonsmokers ac-
cording to their smoking habits. Smoking psoriatic patients ﬁlled
out the Turkish version of the six-item Fagerstrom Test for Nicotine
Dependency (FTND).21 The FTND is one of the most widely used
tests in the measurement of nicotine dependence levels; there are
ﬁve dependency levels, fromvery low to very high dependence. The
FTND is a test including six questions and evaluates dependence on
a scale from very low to very high. It has been widely adopted for
use in both clinical and research settings as a measure of psycho-
logical dependence on nicotine. Its reliability and validity in Turkish
society has been examined by Uysal et al.21
The PASI, Ways of Coping Questionnaire (WCQ) total and sub-
group and DLQI scores of smokers and nonsmokers were compared
statistically. Statistical analyses related to the FTND were only
carried out in smoking groups. Chi-squared test, t test, t test in
independent groups, ManneWhitney U test, and Pearson’s corre-
lation test in SPSS 11.5 were used for statistical evaluations.
TheWCQ is an inventory developed by Folkman and Lazarus and
its Turkish version was adopted by Sahin and Durak.22 The scale
consists of 30 questions and ﬁve subscales [trustful approach (TA),
optimistic approach (OA), submissiveness (S), distrustful approachTable 1 Nicotine dependence level of patients according to the Fagerstrom Test for
Nicotine Dependence.
Fagerstom test grade n %
Very low dependence 20 50.0
Low dependence 10 25.0
Medium dependence 3 7.5
High dependence 5 12.5
Very high dependence 2 5.0(DA) and seeking social support approach (SSS)]. The ﬁrst three are
considered active approaches with respect to problem solving and
the other two are passive approaches to emotions.
Results
Forty patients out of the cohort were current smokers (40.4%).
Current smokers had smoked regularly every day at least for 6
months. The nonsmoking group consisted of those who had quit
smoking at least 6 months ago, those who smoke very rarely and
thosewho have never smoked. Ten smokers (25.0%) had amedium-
to high-level of nicotine dependence according to the FTND
(Table 1). The mean FTND score was 3.13 ( 2.4). Forty-one percent
of smokers stated that smoking had decreased their stress level.
When smokers and nonsmokers were statistically compared,
there was no difference regarding age (p¼ 0.654), sex (p¼ 0.147),
marital status (p¼ 0.449), and educational status (p¼ 0.118)
(Table 2). When clinical characteristics and anamnestic data related
to psoriasis were considered, there was no signiﬁcant difference
between the two groups (Table 3). The presence of another chronic
illness and/or psychiatric disease were also investigated and no
statistical difference was shown (p¼ 0.485 and p¼ 0.552,
respectively).
Both smokers and nonsmokers preferred similar coping strate-
gies and their ranking of the strategies was the same. (Ranking
scores were calculated by dividing themean score by themaximum
score.) Considering the scores of the subscales, the SSS scores were
lower in smokers than nonsmokers, and this was the only differ-
ence that was statistically signiﬁcant (p< 0.05). In fact, all of the
scores were lower in smokers than nonsmokers, yet the difference
was not statistically meaningful except for SSS (Table 4).
Pearson’s correlation test was performed to determine the link
between the FTND, WCQ sub scores and PASI scores. There was
positive correlation between FTND, DA (p¼ 0.036, r¼ 0.333) andPlaque 36 53
Guttate 2 1
Pustular 2 3
Palmoplantar 0 2
Duration of illness (days) 111.80  105.78 120.00  106.27 0.512
Systemic drug use 18 29 0.685
Psoriasis area severity indexb 7.45  4.38 6.6  3.49 0.170
Dermatology life quality indexb 9.43  6.63 9.41  7.57 0.761
a Chi-squared test could not be performed because the number of patients was
inadequate
b ManneWhitney U test was used for analysis.
Table 4 Comparison of the stress coping strategies in smokers and nonsmokers.
Coping strategies of the patient subgroups Smoking status Number of patients Mean Std Minemax score t p
Optimistic approach Smokers 40 9.45 2.80 0e15 0.914 0.363
Nonsmokers 59 10.00 3.02
Distrustful approach Smokers 40 10.82 5.54 0e24 0.461 0.647
Nonsmokers 59 11.29 3.78
Submissiveness Smokers 40 7.00 4.51 0e18 1.094 0.277
Nonsmokers 59 7.98 4.30
Trustful approach Smokers 40 14.65 3.51 0e21 1.217 0.224
Nonsmokers 59 15.08 4.71
Seeking social support Smokers 40 6.67 2.95 0e12 2.272 0.023
Nonsmokers 59 7.95 1.94
Bold indicates *p < 0.05 which is statistically signiﬁcant.
The t test was used for analysis.
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(p¼ 0.000, r¼ 0.391) and DA scores (p¼ 0.001, r¼ 0.332) in all
patients. There was a positive correlation between DLQI and PASI
scores without FTND scores (p¼ 0.000, r¼ 0.495) in nonsmokers.Discussion
Psoriasis is a disabling disease that seriously diminishes life quality
and leads to psychosocial consequences. Poor self-esteem, depres-
sion and even suicidal ideation, anxiety, and personality disorders
are associated with the psychological morbidities of psoriasis. There
are numerous studies reporting psychosocial morbidity in the dis-
ease and thus there is a wide consensus considering psychosocial
factors, such as emotional stress, at the onset and development of
the disease. Although there are a few studies indicating that stress
does not worsen psoriasis, the link between these two has been
demonstrated in many studies,3,23e30 therefore the results on the
topic are variable. There are limited studies, however, demonstrating
the coping strategies of psoriatic patients. In these studies, planning,
acceptance and active coping have been reported as the most
frequently employed coping strategies.25,28,30 In our study, we used a
different instrument (WCQ) to determine patients’ ways of coping
with stress. Its Turkish version consists of ﬁve subgroups according
to factor analyses results. However, assessment of the test focuses on
two issues: problem-focused/active coping and emotion-focused/
passive coping. TA, OA and SSS are the active stress-coping strate-
gies; DA and S are accepted as passive.
When evaluating mechanisms of coping with stress, there was
no statistical difference between smokers and nonsmokers in terms
of patients’ strategies except in seeking social support. The most
frequently employed coping mechanisms in both groups were TA,
OA, and SSS, which were active coping strategies. However,
smokers are less likely to seek social support than nonsmokers
when they experience a stressful situation, and perhaps prefer
cigarette smoking as away to relieve stress. Although both smokers
and nonsmokers employed active coping mechanisms, one of our
study limitations was that we did not the compare the coping
mechanisms of psoriatics with those of healthy controls. This could
be addressed in a further investigation so it would be possible to
discuss whether psoriatic patients employ different coping strate-
gies than people without the illness.
In amulticenter study conducted by Finzi et al, active coping and
planning have been reported to be the most frequently employed
coping strategies by psoriatic patients.28 Fortune et al reported that
acceptance, planning, active coping and positive reinterpretation
are the most frequently used coping strategies in psoriatics.30 Our
results seem to be consistent with these studies. Considering the
relationship between coping strategies, smoking dependence level
and disease severity, the fact that PASI, DA and FTND scores areincreased in smokers means that smoking addiction increases with
the severity of the disease and the level of DA.
Fortes et al were able to show an association between the
severity of psoriasis and the intensity of smoking, deﬁned by daily
cigarette consumption, and found that patients were at amore than
twofold greater risk of severe psoriasis when smoking intensively.
They highlighted the importance of smoking cessation in patients
with psoriasis.11 Some studies demonstrated this correlation,
particularly in male smokers,7,31 although there was no difference
between the sexes in our study. Additionally, the positive correla-
tion between the DLQI and PASI scores without FTND scores in
nonsmokers suggest that quality of life and severity of disease are
related to each other regardless of smoking status. Researchers
investigating the association between psoriasis and smoking have
previously pointed out a signiﬁcant etiopathogenetic role of ciga-
rette smoking and have indicated that cigarette smoking is a risk
factor for the disease.1,4,11,12,15,27,31 In fact, nicotine is a psychoactive
substance and smokers believe that smoking lowers their stress
and anxiety level in general.9,10,16,17,32
An association has been found between alexithymia and psori-
asis in previous studies. Attachment-related avoidance or not
seeking support has been emphasized in psoriatic patients.25,33,34
Other psychiatric associations, such as depression and anxiety,
can be related to smoking and complicate the situation at this
point.29 This is, actually, another limitation to our study, as we did
not examine the associated psychiatric disorders in detail, thinking
that numerous variables would have been involved, creating
complexity. Despite this, neither group showed any signiﬁcant
statistical difference with regard to the presence of psychiatric
disease.
Another limitation is the cross-sectional study design; no causal
link can be demonstrated between smoking addiction and psoria-
sis. It is difﬁcult to state whether psoriasis leads to smoking or vice
versa. Nevertheless, our purpose was not to demonstrate causality
but to question whether there is a relation between smoking and
emotional stress in psoriatic patients. Moreover, there was no sta-
tistically signiﬁcant difference in the duration of disease between
current smokers and nonsmokers.Conclusion
Both groups demonstrated similar stress coping strategies. SSS was
problematic in the smoking group, where possibly smoking had
replaced social help. Nevertheless, no difference was seen between
the two groups in terms of coping strategies. This point may be of
importancewith patients coming for help for psoriasis. It is possible
that when confronted with stress, the patient resorts to cigarette
smoking rather than collaborating with the therapist and searching
for methods of stress reduction. This mechanism will serve to
I. Altunay et al. / Dermatologica Sinica 31 (2013) 130e133 133impair patient compliance rather than alleviate the stress. The
alertness of the therapist will may provide better, healthy
communication with patients with psoriasis, leading to better pa-
tient compliance and smoking cessation. It should be borne inmind
that smoking cessation may result in a better clinical outcome in
psoriasis, as indicated by previous studies showing that smoking
worsened the severity of psoriasis and that patients who smoked
tended to be less responsive to treatment.11,13,31,35,36 Yet, future
prospective studies focusing on causality are required to address
the exact link between smoking, psoriasis and psychiatric comor-
bidity, and also to determine the main targets in prevention and
management of the disease.References
1. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and
stressful life events as risk factors for psoriasis: results from an Italian case-
control study. J Invest Dermatol 2005;125:61e7.
2. Ozguven HD, Kundakçı N, Kumbasar H, Boyvat A. The depression, anxiety, life
satisfaction and affective expression levels in psoriasis patients. JEADV
2000;14:267e71.
3. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review.
Australas J Dermatol 2004;45:155e9.
4. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related
to psoriasis among women. Br J Dermatol 1994;130:473e7.
5. Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis:
an opportunity to identify cardiovascular risk. Br J Dermatol 2009;160:1e7.
6. Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits.
Dermatol Ther 2010;23:174e80.
7. Behnam SM, Behnam SE, Koo J. Smoking and psoriasis. Skinmed 2005;4:174e6.
8. Dellavalle RP, Johnson KR. Do smoking, obesity and stress cause psoriasis?
J Invest Dermatol 2005;125:6e8.
9. Pomerleau OF, Pomerleau CS. Research on stress and smoking: progress and
problems. Br J Addict 1991;86:599e603.
10. Silverstein B. Cigarette smoking. Nicotine addiction, and relaxation. J Pers Soc
Psychol 1982;42:946e50.
11. Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the
clinical severity of psoriasis. Arch Dermatol 2005;141:1580e4.
12. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on
psoriasis presentation and management. Arch Dermatol 2005;141:1527e34.
13. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women:
nurses’ health study II. Am J Med 2007;120:953e9.
14. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and
smoking among hospitaletreated patients with psoriasis. Arch Dermatol
1999;135:1490e3.
15. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav
Genet 1995;25:95e101.16. Aronson KR, Almeida DM, Stawski RS, Klein LC, Kozlowski LT. Smoking is
associated with worse mood on stressful days: results from a national diary
study. Ann Behav Med 2008;36:259e69.
17. Todd M. Daily processes in stress and smoking: effects of negative events,
nicotine dependence, and gender. Psychol Addict Behav 2004;18:31e9.
18. Naldi L. Cigarette smoking and psoriasis. Clinics in Dermatology 1998;16:571e4.
19. Dauden E, Castaneda S, Suarez C, et al. Integrated approach to comorbidity in
patients with psoriasis. Working group on psoriasis associated comorbidities.
Actas Dermosiﬁlogr 2012;103:1e64.
20. Oztürkcan S, Ermertcan AT, Eser E, et al. Cross validation of the Turkish version
of dermatology life quality index. Int J Dermatol 2006;45:1300e7.
21. Uysal MA, Kadakal F, Kars¸idag C, et al. Fagerstrom test for nicotine depen-
dence: reliability in a Turkish sample and factor analysis. Tuberk Toraks
2004;52:115e21.
22. S¸ahin NH, Durak A. Ways of stress coping strategies scale: application to uni-
versity students. Türk Psikoloji Dergisi 1995;10:56e73.
23. Berg M, Svensson M, Brandberg M, et al. Psoriasis and stress: a prospective
study. JEADV 2008;22:670e4.
24. Payne RA, Rowland Payne CM, Marks R. Stress does not worsen psoriasis? A
controlled study of 32 patients. Clin Exp Dermatol 1985;10:239e45.
25. Picardi A, Mazzotti E, Gaetano P, et al. Stress, social support, emotional regu-
lation, and exacerbation of diffuse plaque psoriasis. Psychosomatics 2005;46:
556e64.
26. Al-Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and
the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol
1994;30:199e203.
27. Smith CS, Barker JNWN. Psoriasis and its management. BMJ 2008;333:380e4.
28. Finzi A, Colombo D, Caputo A, et al. PSYCHAE Study Group Psychological
distress and coping strategies in patients with psoriasis: the PSYCHAE Study.
J Eur Acad Dermatol Venereol 2007;21:1161e9.
29. Fortune DG, Richards HL, Grifﬁths CE, et al. Psychological stress, distress and
disability in patients with psoriasis: consensus and variation in the contribu-
tion of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002;41:
157e74.
30. Fortune DG, Richards HL, Main CJ, et al. Patients’ strategies for coping with
psoriasis. Clin Exp Dermatol 2002;27:177e84.
31. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U. Smoking and alcohol intake in
severely affected patients with psoriasis in Germany. Dermatology 2010;220:
38e43.
32. Hughes JR. Nicotine-related disorders. In: Sadock BJ, Sadocj VA, editors.
Kaplan’s & Sadok’s comprehensive textbook of psychiatry. 7th ed. Philadelphia:
Lippincott Williams & Wilkins; 2000. p. 1033e8.
33. Consoli SM, Rolhion S, Martin C, et al. Low levels of emotional awareness
predict a better response to dermatological treatment in patients with psori-
asis. Dermatology 2006;212:128e36.
34. Willemsen R, Roseeuw D, Vanderlinden J. Alexithymia and dermatology: the
state of the art. Int J Dermatol 2008;47:903e10.
35. Naldi I, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and
male alcohol consumption: evidence from an Italian case-control study. Arch
Dermatol 1999;135:1479e84.
36. Li W, Han J, Choi HK, et al. Smoking and risk of incident psoriasis among
women and men in the United States: a combined analysis. Am J Epidemiol
2012;175:402e13.
